Drug Shortage Report for MINT-GLICLAZIDE MR
| Report ID | 108289 |
| Drug Identification Number | 02423294 |
| Brand name | MINT-GLICLAZIDE MR |
| Common or Proper name | Gliclazide |
| Company Name | MINT PHARMACEUTICALS INC |
| Market Status | DORMANT |
| Active Ingredient(s) | GLICLAZIDE |
| Strength(s) | 60MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 100 count bottles |
| ATC code | A10BB |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | |
| Actual start date | 2020-03-09 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2020-03-10 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2020-03-10 | English | Compare |
| v2 | 2020-03-09 | French | Compare |
| v1 | 2020-03-09 | English | Compare |
Showing 1 to 3 of 3